Finally, CD8+ T cells are more frequent in blood of CAD patients than in healthy individuals (295, 296) and generally associated with pro-atherosclerotic effects in preclinical studies (297–299), but, in contrast, inhibiting CD8+ cells in advanced lesions also resulted in less stable lesions (300). This evidence concerns the gene CD8A and coronary artery disorder.